Russian Sputnik V vaccine shows 96.3% COVID-19 efficacy in Belarus – RDIF – Community News
Covid-19

Russian Sputnik V vaccine shows 96.3% COVID-19 efficacy in Belarus – RDIF

Doses of the Sputnik V vaccine against the coronavirus disease (COVID-19) are seen at a vaccination center in Zilina, Slovakia on June 7, 2021. REUTERS/Radovan Stoklasa

MOSCOW, Nov 17 (Reuters) – Russia’s Sputnik V vaccine has demonstrated 96.3% efficacy against COVID-19 during the vaccination campaign in Belarus, Russia’s RDIF state fund said on Wednesday, showing a drop in efficacy from 97.2% reported in September.

The Russian Direct Investment Fund, which markets the dual vaccine abroad, said the study was based on data from more than 1.2 million people vaccinated with both Sputnik V components between January and September 2021.

Reporting by Maria Kiselyova; Writing by Alexander Marrow

Our Standards: The Thomson Reuters Trust Principles.